Veterinary Pharmaceuticals-EMEA Market Status and Trend Report 2013-2023
Report Summary
Veterinary Pharmaceuticals-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Veterinary Pharmaceuticals industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Veterinary Pharmaceuticals 2013-2017, and development forecast 2018-2023
Main market players of Veterinary Pharmaceuticals in EMEA, with company and product introduction, position in the Veterinary Pharmaceuticals market
Market status and development trend of Veterinary Pharmaceuticals by types and applications
Cost and profit status of Veterinary Pharmaceuticals, and marketing status
Market growth drivers and challenges
The report segments the EMEA Veterinary Pharmaceuticals market as:
EMEA Veterinary Pharmaceuticals Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Veterinary Pharmaceuticals Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Veterinary Biological Drugs
Veterinary Preparations
Others
EMEA Veterinary Pharmaceuticals Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Poultry
Pets
Other
EMEA Veterinary Pharmaceuticals Market: Players Segment Analysis (Company and Product introduction, Veterinary Pharmaceuticals Sales Volume, Revenue, Price and Gross Margin):
Zoetis(Pfizer)
MERIAL
Merial
Lilly
Bayer
Boehringer
Novartis
Virbac
Ceva
Vetoquinol
CAHIC
Ringpu
Dahuanong
TECON
BIOK
Lukang Pharma
JINYU Group
China Animal Healthcare
Jiangxi Yiling
JIZHONG Pharmaceutical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Veterinary Pharmaceuticals-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Veterinary Pharmaceuticals industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Veterinary Pharmaceuticals 2013-2017, and development forecast 2018-2023
Main market players of Veterinary Pharmaceuticals in EMEA, with company and product introduction, position in the Veterinary Pharmaceuticals market
Market status and development trend of Veterinary Pharmaceuticals by types and applications
Cost and profit status of Veterinary Pharmaceuticals, and marketing status
Market growth drivers and challenges
The report segments the EMEA Veterinary Pharmaceuticals market as:
EMEA Veterinary Pharmaceuticals Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Veterinary Pharmaceuticals Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Veterinary Biological Drugs
Veterinary Preparations
Others
EMEA Veterinary Pharmaceuticals Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Poultry
Pets
Other
EMEA Veterinary Pharmaceuticals Market: Players Segment Analysis (Company and Product introduction, Veterinary Pharmaceuticals Sales Volume, Revenue, Price and Gross Margin):
Zoetis(Pfizer)
MERIAL
Merial
Lilly
Bayer
Boehringer
Novartis
Virbac
Ceva
Vetoquinol
CAHIC
Ringpu
Dahuanong
TECON
BIOK
Lukang Pharma
JINYU Group
China Animal Healthcare
Jiangxi Yiling
JIZHONG Pharmaceutical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF VETERINARY PHARMACEUTICALS
1.1 Definition of Veterinary Pharmaceuticals in This Report
1.2 Commercial Types of Veterinary Pharmaceuticals
1.2.1 Veterinary Biological Drugs
1.2.2 Veterinary Preparations
1.2.3 Others
1.3 Downstream Application of Veterinary Pharmaceuticals
1.3.1 Poultry
1.3.2 Pets
1.3.3 Other
1.4 Development History of Veterinary Pharmaceuticals
1.5 Market Status and Trend of Veterinary Pharmaceuticals 2013-2023
1.5.1 EMEA Veterinary Pharmaceuticals Market Status and Trend 2013-2023
1.5.2 Regional Veterinary Pharmaceuticals Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Veterinary Pharmaceuticals in EMEA 2013-2017
2.2 Consumption Market of Veterinary Pharmaceuticals in EMEA by Regions
2.2.1 Consumption Volume of Veterinary Pharmaceuticals in EMEA by Regions
2.2.2 Revenue of Veterinary Pharmaceuticals in EMEA by Regions
2.3 Market Analysis of Veterinary Pharmaceuticals in EMEA by Regions
2.3.1 Market Analysis of Veterinary Pharmaceuticals in Europe 2013-2017
2.3.2 Market Analysis of Veterinary Pharmaceuticals in Middle East 2013-2017
2.3.3 Market Analysis of Veterinary Pharmaceuticals in Africa 2013-2017
2.4 Market Development Forecast of Veterinary Pharmaceuticals in EMEA 2018-2023
2.4.1 Market Development Forecast of Veterinary Pharmaceuticals in EMEA 2018-2023
2.4.2 Market Development Forecast of Veterinary Pharmaceuticals by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Veterinary Pharmaceuticals in EMEA by Types
3.1.2 Revenue of Veterinary Pharmaceuticals in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Veterinary Pharmaceuticals in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Veterinary Pharmaceuticals in EMEA by Downstream Industry
4.2 Demand Volume of Veterinary Pharmaceuticals by Downstream Industry in Major Countries
4.2.1 Demand Volume of Veterinary Pharmaceuticals by Downstream Industry in Europe
4.2.2 Demand Volume of Veterinary Pharmaceuticals by Downstream Industry in Middle East
4.2.3 Demand Volume of Veterinary Pharmaceuticals by Downstream Industry in Africa
4.3 Market Forecast of Veterinary Pharmaceuticals in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF VETERINARY PHARMACEUTICALS
5.1 EMEA Economy Situation and Trend Overview
5.2 Veterinary Pharmaceuticals Downstream Industry Situation and Trend Overview
CHAPTER 6 VETERINARY PHARMACEUTICALS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Veterinary Pharmaceuticals in EMEA by Major Players
6.2 Revenue of Veterinary Pharmaceuticals in EMEA by Major Players
6.3 Basic Information of Veterinary Pharmaceuticals by Major Players
6.3.1 Headquarters Location and Established Time of Veterinary Pharmaceuticals Major Players
6.3.2 Employees and Revenue Level of Veterinary Pharmaceuticals Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 VETERINARY PHARMACEUTICALS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Zoetis(Pfizer)
7.1.1 Company profile
7.1.2 Representative Veterinary Pharmaceuticals Product
7.1.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Zoetis(Pfizer)
7.2 MERIAL
7.2.1 Company profile
7.2.2 Representative Veterinary Pharmaceuticals Product
7.2.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of MERIAL
7.3 Merial
7.3.1 Company profile
7.3.2 Representative Veterinary Pharmaceuticals Product
7.3.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Merial
7.4 Lilly
7.4.1 Company profile
7.4.2 Representative Veterinary Pharmaceuticals Product
7.4.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Lilly
7.5 Bayer
7.5.1 Company profile
7.5.2 Representative Veterinary Pharmaceuticals Product
7.5.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Bayer
7.6 Boehringer
7.6.1 Company profile
7.6.2 Representative Veterinary Pharmaceuticals Product
7.6.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Boehringer
7.7 Novartis
7.7.1 Company profile
7.7.2 Representative Veterinary Pharmaceuticals Product
7.7.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Novartis
7.8 Virbac
7.8.1 Company profile
7.8.2 Representative Veterinary Pharmaceuticals Product
7.8.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Virbac
7.9 Ceva
7.9.1 Company profile
7.9.2 Representative Veterinary Pharmaceuticals Product
7.9.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Ceva
7.10 Vetoquinol
7.10.1 Company profile
7.10.2 Representative Veterinary Pharmaceuticals Product
7.10.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Vetoquinol
7.11 CAHIC
7.11.1 Company profile
7.11.2 Representative Veterinary Pharmaceuticals Product
7.11.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of CAHIC
7.12 Ringpu
7.12.1 Company profile
7.12.2 Representative Veterinary Pharmaceuticals Product
7.12.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Ringpu
7.13 Dahuanong
7.13.1 Company profile
7.13.2 Representative Veterinary Pharmaceuticals Product
7.13.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Dahuanong
7.14 TECON
7.14.1 Company profile
7.14.2 Representative Veterinary Pharmaceuticals Product
7.14.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of TECON
7.15 BIOK
7.15.1 Company profile
7.15.2 Representative Veterinary Pharmaceuticals Product
7.15.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of BIOK
7.16 Lukang Pharma
7.17 JINYU Group
7.18 China Animal Healthcare
7.19 Jiangxi Yiling
7.20 JIZHONG Pharmaceutical
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF VETERINARY PHARMACEUTICALS
8.1 Industry Chain of Veterinary Pharmaceuticals
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF VETERINARY PHARMACEUTICALS
9.1 Cost Structure Analysis of Veterinary Pharmaceuticals
9.2 Raw Materials Cost Analysis of Veterinary Pharmaceuticals
9.3 Labor Cost Analysis of Veterinary Pharmaceuticals
9.4 Manufacturing Expenses Analysis of Veterinary Pharmaceuticals
CHAPTER 10 MARKETING STATUS ANALYSIS OF VETERINARY PHARMACEUTICALS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Veterinary Pharmaceuticals in This Report
1.2 Commercial Types of Veterinary Pharmaceuticals
1.2.1 Veterinary Biological Drugs
1.2.2 Veterinary Preparations
1.2.3 Others
1.3 Downstream Application of Veterinary Pharmaceuticals
1.3.1 Poultry
1.3.2 Pets
1.3.3 Other
1.4 Development History of Veterinary Pharmaceuticals
1.5 Market Status and Trend of Veterinary Pharmaceuticals 2013-2023
1.5.1 EMEA Veterinary Pharmaceuticals Market Status and Trend 2013-2023
1.5.2 Regional Veterinary Pharmaceuticals Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Veterinary Pharmaceuticals in EMEA 2013-2017
2.2 Consumption Market of Veterinary Pharmaceuticals in EMEA by Regions
2.2.1 Consumption Volume of Veterinary Pharmaceuticals in EMEA by Regions
2.2.2 Revenue of Veterinary Pharmaceuticals in EMEA by Regions
2.3 Market Analysis of Veterinary Pharmaceuticals in EMEA by Regions
2.3.1 Market Analysis of Veterinary Pharmaceuticals in Europe 2013-2017
2.3.2 Market Analysis of Veterinary Pharmaceuticals in Middle East 2013-2017
2.3.3 Market Analysis of Veterinary Pharmaceuticals in Africa 2013-2017
2.4 Market Development Forecast of Veterinary Pharmaceuticals in EMEA 2018-2023
2.4.1 Market Development Forecast of Veterinary Pharmaceuticals in EMEA 2018-2023
2.4.2 Market Development Forecast of Veterinary Pharmaceuticals by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Veterinary Pharmaceuticals in EMEA by Types
3.1.2 Revenue of Veterinary Pharmaceuticals in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Veterinary Pharmaceuticals in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Veterinary Pharmaceuticals in EMEA by Downstream Industry
4.2 Demand Volume of Veterinary Pharmaceuticals by Downstream Industry in Major Countries
4.2.1 Demand Volume of Veterinary Pharmaceuticals by Downstream Industry in Europe
4.2.2 Demand Volume of Veterinary Pharmaceuticals by Downstream Industry in Middle East
4.2.3 Demand Volume of Veterinary Pharmaceuticals by Downstream Industry in Africa
4.3 Market Forecast of Veterinary Pharmaceuticals in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF VETERINARY PHARMACEUTICALS
5.1 EMEA Economy Situation and Trend Overview
5.2 Veterinary Pharmaceuticals Downstream Industry Situation and Trend Overview
CHAPTER 6 VETERINARY PHARMACEUTICALS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Veterinary Pharmaceuticals in EMEA by Major Players
6.2 Revenue of Veterinary Pharmaceuticals in EMEA by Major Players
6.3 Basic Information of Veterinary Pharmaceuticals by Major Players
6.3.1 Headquarters Location and Established Time of Veterinary Pharmaceuticals Major Players
6.3.2 Employees and Revenue Level of Veterinary Pharmaceuticals Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 VETERINARY PHARMACEUTICALS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Zoetis(Pfizer)
7.1.1 Company profile
7.1.2 Representative Veterinary Pharmaceuticals Product
7.1.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Zoetis(Pfizer)
7.2 MERIAL
7.2.1 Company profile
7.2.2 Representative Veterinary Pharmaceuticals Product
7.2.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of MERIAL
7.3 Merial
7.3.1 Company profile
7.3.2 Representative Veterinary Pharmaceuticals Product
7.3.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Merial
7.4 Lilly
7.4.1 Company profile
7.4.2 Representative Veterinary Pharmaceuticals Product
7.4.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Lilly
7.5 Bayer
7.5.1 Company profile
7.5.2 Representative Veterinary Pharmaceuticals Product
7.5.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Bayer
7.6 Boehringer
7.6.1 Company profile
7.6.2 Representative Veterinary Pharmaceuticals Product
7.6.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Boehringer
7.7 Novartis
7.7.1 Company profile
7.7.2 Representative Veterinary Pharmaceuticals Product
7.7.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Novartis
7.8 Virbac
7.8.1 Company profile
7.8.2 Representative Veterinary Pharmaceuticals Product
7.8.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Virbac
7.9 Ceva
7.9.1 Company profile
7.9.2 Representative Veterinary Pharmaceuticals Product
7.9.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Ceva
7.10 Vetoquinol
7.10.1 Company profile
7.10.2 Representative Veterinary Pharmaceuticals Product
7.10.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Vetoquinol
7.11 CAHIC
7.11.1 Company profile
7.11.2 Representative Veterinary Pharmaceuticals Product
7.11.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of CAHIC
7.12 Ringpu
7.12.1 Company profile
7.12.2 Representative Veterinary Pharmaceuticals Product
7.12.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Ringpu
7.13 Dahuanong
7.13.1 Company profile
7.13.2 Representative Veterinary Pharmaceuticals Product
7.13.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of Dahuanong
7.14 TECON
7.14.1 Company profile
7.14.2 Representative Veterinary Pharmaceuticals Product
7.14.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of TECON
7.15 BIOK
7.15.1 Company profile
7.15.2 Representative Veterinary Pharmaceuticals Product
7.15.3 Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin of BIOK
7.16 Lukang Pharma
7.17 JINYU Group
7.18 China Animal Healthcare
7.19 Jiangxi Yiling
7.20 JIZHONG Pharmaceutical
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF VETERINARY PHARMACEUTICALS
8.1 Industry Chain of Veterinary Pharmaceuticals
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF VETERINARY PHARMACEUTICALS
9.1 Cost Structure Analysis of Veterinary Pharmaceuticals
9.2 Raw Materials Cost Analysis of Veterinary Pharmaceuticals
9.3 Labor Cost Analysis of Veterinary Pharmaceuticals
9.4 Manufacturing Expenses Analysis of Veterinary Pharmaceuticals
CHAPTER 10 MARKETING STATUS ANALYSIS OF VETERINARY PHARMACEUTICALS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
